Biomea Fusion BMEA
NASDAQ BMEA
$0.62 +0.03 (+5.30%)
As of: Oct 23, 2026 · 2:15 PM EDT

Biomea Fusion (BMEA) Purchase of Investments (2021)

Updated

Analysis

Biomea Fusion (BMEA) Purchase of Investments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 919.00 Mn
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn 834.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn -
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 2.54 Bn
10 Biomea Fusion 45.05 Mn -137.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 49,000.00
Mar 31, 2021 38.44 Mn
API Access

Biomea Fusion Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=BMEA&period=max&api_key=YOUR_API_KEY